Sami Labs, manufacturer and marketer of products for the pharmaceutical and food industries and parent company of phytonutrient supplier and research firm Sabinsa, recently inaugurated its second continuous extraction plant, largely to satisfy demand for its Curcumin C3 Complex.
Despite a flood of artificial ingredients in the food, supplement and cosmetic industries, conscious consumers continue to insist upon natural herbal extracts in the products they consume.
Sami has dedicated the new facility exclusively to curcumin extraction and intends for the plant to increase the company’s production capacity of natural, bioavailable Curcumin C3 Complex fourfold, taking the previous production of 6 tons to 25 tons. Both continuous extraction units are situated across 5 acres in Dobaspet, Bengaluru, India.
Preference for natural curcumin, coupled with continuing research supporting its benefits, has yielded a curcumin market set to exceed $100 million by 2023, representing a CAGR of 12.6 percent from 2017 to 2023.
Though dietary supplements, pharmaceuticals and cosmetics still drive curcumin’s growth, nutraceuticals are responsible for more than half of curcumin demand share by volume and revenue, and continue to grow faster than the other segments.